-
Congratulations! Shenzhen Neoimmune Co., Ltd's product has been selected for the 2024 VBEF Healthcare Industry Innovation Product List.
From May 8th to 10th, 2024, the 8th Future Healthcare Ecosystem Expo (VBEF) took place in Beijing. T...
10
2024.05
-
The first domestic hematological tumor MRD detection product was approved by CE, and Shenzhen Neoimmune Co., Ltd has built a benchmark enterprise for clinical immunodetection
MRD (Minimal Residual Disease) refers to the state of trace tumor cells remaining in the body after ...
09
2022.03